Breadcrumb

Breadcrumbs

Press Releases

Search Results

Back to Press Releases
Showing 1 - 10 of 43 results.

You searched for : February 2020 to February 2021.

Daiichi Sankyo and LYSA-LYSARC-CALYM Enter Research Collaboration for Valemetostat in Patients with ...

Daiichi Sankyo and LYSA-LYSARC-CALYM Enter Research Collaboration for Valemetostat in Patients with Relapsed/Refractory B-Cell Lymphoma Download the PDF version of Article February 24, 2021 Phase 2...

Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D

Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D Download the PDF version of Article February 22, 2021 Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D Tokyo, Munich...

New Survey Reveals Nearly Half of Women Are Unfamiliar with a Condition that Affects Up to Five Mil ...

New Survey Reveals Nearly Half of Women Are Unfamiliar with a Condition that Affects Up to Five Million Adults in the U.S. Download the PDF version of Article February 17, 2021 New Survey Reveals...

HERTHENA-Lung01 Phase 2 Study of Daiichi Sankyo’s Patritumab Deruxtecan Initiated in Patients with ...

HERTHENA-Lung01 Phase 2 Study of Daiichi Sankyo’s Patritumab Deruxtecan Initiated in Patients with EGFR-Mutated NSCLC Download the PDF version of Article February 03, 2021 HERTHENA-Lung01 Phase 2...

Daiichi Sankyo Initiates Clinical Development of Sixth DXd ADC DS-6000 with Sarah Cannon Research I ...

Daiichi Sankyo Initiates Clinical Development of Sixth DXd ADC DS-6000 with Sarah Cannon Research Institute Download the PDF version of Article February 02, 2021 Daiichi Sankyo Initiates Clinical...

Datopotamab Deruxtecan and ENHERTU® Show Promising Early Clinical Activity in Patients with Advance ...

Datopotamab Deruxtecan and ENHERTU® Show Promising Early Clinical Activity in Patients with Advanced Non-Small Cell Lung Cancer Download the PDF version of Article January 29, 2021 Data at WCLC...

​​​​​​​New Biomarker Analyses from Patritumab Deruxtecan Phase 1 Study in Patients with EGFR-Mutate ...

New Biomarker Analyses from Patritumab Deruxtecan Phase 1 Study in Patients with EGFR-Mutated NSCLC Presented at WCLC 2020 Download the PDF version of Article January 29, 2021 Munich and Basking...

ENHERTU® Receives Prime Minister’s Award from the Japan Techno-Economics Society

ENHERTU® Receives Prime Minister’s Award from the Japan Techno-Economics Society Download the PDF version of Article January 27, 2021 Tokyo, Munich and Basking Ridge, NJ – (January 27, 2021) –...

ENHERTU® Approved in the U.S. for the Treatment of Patients with Previously Treated HER2 Positive A ...

ENHERTU® Approved in the U.S. for the Treatment of Patients with Previously Treated HER2 Positive Advanced Gastric Cancer   Download the PDF version of Article January 15, 2021 First HER2 directed...

New Research Data Across DXd ADC Portfolio at WCLC Showcases Daiichi Sankyo’s Continued Commitment ...

New Research Data Across DXd ADC Portfolio at WCLC Showcases Daiichi Sankyo’s Continued Commitment in Lung Cancer January 13, 2021 Interim DESTINY-Lung01 research data from the HER2 overexpressing...

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...